​
​

Seer (SEER) Revenue & Revenue Breakdown

OverviewOwnershipFinancialsChartTranscripts

Seer Revenue Highlights

Latest Revenue (Y)

$16.66M

Latest Revenue (Q)

$4.03M

Main Segment (Y)

Grant

Seer Revenue by Period

Seer Revenue by Year

DateRevenueChange
2023-12-31-13.46%
2022-12-31-129.67%
2021-12-31-874.70%
2020-12-31-1031.03%
2019-12-31-100.00%
2018-12-31--

Seer generated $16.66M in revenue during NA 2023, up 13.46% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

Seer Revenue by Quarter

DateRevenueChange
2024-09-30-31.25%
2024-06-30-0.20%
2024-03-31--26.65%
2023-12-31-9.60%
2023-09-30-9.91%
2023-06-30--6.67%
2023-03-31--3.65%
2022-12-31--2.43%
2022-09-30-10.75%
2022-06-30-8.28%
2022-03-31-8.77%
2021-12-31-41.35%
2021-09-30-76.25%
2021-06-30-1862.90%
2021-03-31--81.55%
2020-12-31-366.67%
2020-09-30-1.41%
2020-06-30--59.89%
2020-03-31-205.17%
2019-12-31--

Seer generated $4.03M in revenue during Q3 2024, up 31.25% compared to the previous quarter, and up 116.20% compared to the same period a year ago.

Seer Revenue Breakdown

Seer Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 23Dec 22Dec 21
Grant---
Service---
Related Party---
Grant and Other---
Product---

Seer's latest annual revenue breakdown by segment (product or service), as of Dec 23: Grant (100.00%).

Quarterly Revenue by Product

Product/ServiceDec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21
Grant------------
Related Party------------
Grant and Other------------
Product------------
Service------------
Research and Development Activties------------

Seer's latest quarterly revenue breakdown by segment (product or service), as of Dec 23: Grant (100.00%).

Seer Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
KYMRKymera Therapeutics--
NRIXNurix Therapeutics--
FHTXFoghorn Therapeutics--
SEERSeer--
MOLNMolecular Partners--
GBIOGeneration Bio--
HCWBHCW Biologics--
STTKShattuck Labs--
QSIQuantum-Si--
MNOVMediciNova--
LYELLyell Immunopharma--
ANEBAnebulo Pharmaceuticals--
CGEMCullinan Oncology--
CCCCC4 Therapeutics--
ANTXAN2 Therapeutics--
PHVSPharvaris--
NKTXNkarta--
MLYSMineralys Therapeutics--
ORICORIC Pharmaceuticals--
SANASana Bio--
GLUEMonte Rosa Therapeutics--
PEPGPepGen--

SEER Revenue FAQ

What is Seer’s yearly revenue?

Seer's yearly revenue for 2023 was $16.66M, representing an increase of 13.46% compared to 2022. The company's yearly revenue for 2022 was $14.68M, representing an increase of 129.67% compared to 2021. SEER's yearly revenue for 2021 was $6.39M, representing an increase of 874.70% compared to 2020.

What is Seer’s quarterly revenue?

Seer's quarterly revenue for Q3 2024 was $4.03M, a 31.25% increase from the previous quarter (Q2 2024), and a 5.72% increase year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $3.07M, a 0.20% increase from the previous quarter (Q1 2024), and a -11.47% decrease year-over-year (Q2 2023). SEER's quarterly revenue for Q1 2024 was $3.07M, a -26.65% decrease from the previous quarter (Q4 2023), and a -17.54% decrease year-over-year (Q1 2023).

What is Seer’s revenue growth rate?

Seer's revenue growth rate for the last 3 years (2021-2023) was 160.57%, and for the last 5 years (2019-2023) was 28625.86%.

What are Seer’s revenue streams?

Seer's revenue streams in c 23 are Grant

What is Seer’s main source of revenue?

For the fiscal year ending Dec 23, the largest source of revenue of Seer was Grant. This segment made a revenue of $1.1M, representing 100.00% of the company's total revenue.